Those studies revealed that 43% of SLE patients have expanded ARID3a+ B cells, and that total numbers of ARID3a+ B cells were associated with increased disease activity in individual patients assessed at different time points. The gene discussed is ARID3A; the disease is systemic lupus erythematosus.